Search research articles
Contact Us
Filters
Showing results (141-150 of 208) with videos related to
Page
of 21
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 1, 2005
Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism
B M W Schmidt, K Horisberger, M Feuring, et al.
Acta Endocrinologica
|
December 1, 1987
Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism
M Wehling, S Kuhls, H Witzgall, et al.
FEBS Letters
|
June 1, 2000
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
X Zhu, M Hadhazy, M Wehling, et al.
Circulation Research
|
June 1, 1995
Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells
M Wehling, C B Neylon, M Fullerton, et al.
Clinical Science (London, England : 1979)
|
May 1, 1984
Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis?
L Neyses, R Locher, M Wehling, et al.
MMW Fortschritte Der Medizin
|
September 28, 2000
[Guidelines for lowering lipids are too infrequently observed. Results of a retrospective study of coronary heart disease patients]
G Klein, J Ruof, W März, et al.
Preventive Medicine
|
June 25, 2002
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns
J Ruof, G Klein, W März, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1995
Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells
M Christ, K Douwes, C Eisen, et al.
Drug Research
|
October 7, 2014
Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel
P Bahrmann, M Wehling, D Ropers, et al.
MMW Fortschritte Der Medizin
|
November 25, 2014
[Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel]
P Bahrmann, M Wehling, D Ropers, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 208) with videos related to
Sort By:
Page
of 21
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
June 1, 2005
Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism
B M W Schmidt, K Horisberger, M Feuring, et al.
Acta Endocrinologica
|
December 1, 1987
Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism
M Wehling, S Kuhls, H Witzgall, et al.
FEBS Letters
|
June 1, 2000
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
X Zhu, M Hadhazy, M Wehling, et al.
Circulation Research
|
June 1, 1995
Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells
M Wehling, C B Neylon, M Fullerton, et al.
Clinical Science (London, England : 1979)
|
May 1, 1984
Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis?
L Neyses, R Locher, M Wehling, et al.
MMW Fortschritte Der Medizin
|
September 28, 2000
[Guidelines for lowering lipids are too infrequently observed. Results of a retrospective study of coronary heart disease patients]
G Klein, J Ruof, W März, et al.
Preventive Medicine
|
June 25, 2002
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns
J Ruof, G Klein, W März, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1995
Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells
M Christ, K Douwes, C Eisen, et al.
Drug Research
|
October 7, 2014
Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel
P Bahrmann, M Wehling, D Ropers, et al.
MMW Fortschritte Der Medizin
|
November 25, 2014
[Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel]
P Bahrmann, M Wehling, D Ropers, et al.
Page
of 21